Statins show a protective role against HCC as they decrease hepatic expression of angiogenic factors like VEGF receptor, epidermal growth factor receptor (EGFR), and platelet-derived growth factor (PDGF) (Dulak and Józkowicz, 2005; Yokohama et al., 2016). This evidence concerns the gene EGFR and hepatocellular carcinoma.